Results 201 to 210 of about 2,144,828 (297)

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Progress in the study of molecular markers in the prognosis assessment and recurrence patterns of glioblastoma. [PDF]

Cancer Biol Ther
Hu Y, Ge X, Xie Q, Ma R, Tao Q.
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease

Frontiers in Neurology, 2017
Rosanna Squitti, Carlo Salustri, Mauro Rongioletti, Mariacristina Siotto   +3 more
doaj   +1 more source

Analysis of EST-SSR characteristics of prickly ash transcriptome and development of molecular markers. [PDF]

Sci Rep
Liu J, Zhuo S, Xiang S, Du J, Zhang R, Tian A, Liu L, Cai X, Ma Z, Ren Y, Chen Z.   +10 more
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

A review on molecular markers of <i>Plasmodium falciparum</i>. [PDF]

J Parasit Dis
Abebe W, Woldesenbet D.
europepmc   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

Network connectome analysis of multi omics data identifies molecular markers of recurrence and grade progression in meningioma. [PDF]

Front Oncol
Gim JA, Jo HJ, Kwon WK, Ham CH, Roh HW, Yoon W, Kim JH, Kwon TH, Byun J.   +8 more
europepmc   +1 more source